Uni-Bio Science Group Limited (0690.HK)
HKD 0.06
(-11.59%)
HKD 0.06
(-11.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 152.81 Million HKD | 56.38% |
| 2022 | 97.72 Million HKD | 4.76% |
| 2021 | 93.28 Million HKD | 47.36% |
| 2020 | 63.3 Million HKD | 15.1% |
| 2019 | 55 Million HKD | 35.15% |
| 2018 | 40.69 Million HKD | -13.47% |
| 2017 | 47.03 Million HKD | -7.62% |
| 2016 | 50.91 Million HKD | 1.23% |
| 2015 | 50.29 Million HKD | 52.31% |
| 2014 | 33.02 Million HKD | -65.13% |
| 2013 | 94.69 Million HKD | -45.71% |
| 2012 | 174.43 Million HKD | 34.81% |
| 2011 | 129.39 Million HKD | 74.78% |
| 2010 | 74.03 Million HKD | -14.13% |
| 2009 | 86.21 Million HKD | -45.62% |
| 2008 | 158.54 Million HKD | -24.07% |
| 2007 | 208.79 Million HKD | -8.83% |
| 2006 | 229.01 Million HKD | 117.69% |
| 2005 | 105.2 Million HKD | -1.29% |
| 2004 | 106.58 Million HKD | -21.38% |
| 2003 | 135.57 Million HKD | 16.26% |
| 2002 | 116.62 Million HKD | 91.6% |
| 2001 | 60.86 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 174.43 Million HKD | 0.0% |
| 2024 Q1 | 174.43 Million HKD | 14.14% |
| 2023 Q1 | 86.52 Million HKD | -11.46% |
| 2023 Q3 | 152.81 Million HKD | 76.62% |
| 2023 Q2 | 86.52 Million HKD | 0.0% |
| 2023 Q4 | 152.81 Million HKD | 0.0% |
| 2023 FY | 152.81 Million HKD | 56.38% |
| 2022 Q1 | 81.85 Million HKD | -12.26% |
| 2022 Q3 | 97.72 Million HKD | 19.39% |
| 2022 FY | 97.72 Million HKD | 4.76% |
| 2022 Q4 | 97.72 Million HKD | 0.0% |
| 2022 Q2 | 81.85 Million HKD | 0.0% |
| 2021 Q4 | 93.28 Million HKD | 0.0% |
| 2021 FY | 93.28 Million HKD | 47.36% |
| 2021 Q1 | 93.16 Million HKD | 47.17% |
| 2021 Q2 | 93.16 Million HKD | 0.0% |
| 2021 Q3 | 93.28 Million HKD | 0.13% |
| 2020 Q1 | 29.35 Million HKD | -46.62% |
| 2020 FY | 63.3 Million HKD | 15.1% |
| 2020 Q2 | 29.75 Million HKD | 1.35% |
| 2020 Q3 | 63.3 Million HKD | 112.75% |
| 2020 Q4 | 63.3 Million HKD | 0.0% |
| 2019 FY | 55 Million HKD | 35.15% |
| 2019 Q1 | 51.67 Million HKD | 26.97% |
| 2019 Q2 | 51.67 Million HKD | 0.0% |
| 2019 Q3 | 54.59 Million HKD | 5.66% |
| 2019 Q4 | 55 Million HKD | 0.74% |
| 2018 Q2 | 26.66 Million HKD | 5.87% |
| 2018 FY | 40.69 Million HKD | -13.47% |
| 2018 Q3 | 39.48 Million HKD | 48.09% |
| 2018 Q4 | 40.69 Million HKD | 3.09% |
| 2018 Q1 | 25.18 Million HKD | -46.46% |
| 2017 Q4 | 47.03 Million HKD | 3.09% |
| 2017 FY | 47.03 Million HKD | -7.62% |
| 2017 Q3 | 45.62 Million HKD | 72.72% |
| 2017 Q2 | 26.41 Million HKD | 3.87% |
| 2017 Q1 | 25.43 Million HKD | -50.05% |
| 2016 FY | 50.91 Million HKD | 1.23% |
| 2016 Q4 | 50.91 Million HKD | 1.9% |
| 2016 Q3 | 49.96 Million HKD | 9.21% |
| 2016 Q2 | 45.75 Million HKD | 1.88% |
| 2016 Q1 | 44.91 Million HKD | -10.7% |
| 2015 Q4 | 50.29 Million HKD | 1.73% |
| 2015 FY | 50.29 Million HKD | 52.31% |
| 2015 Q3 | 49.44 Million HKD | 64.94% |
| 2015 Q2 | 29.97 Million HKD | 1.77% |
| 2015 Q1 | 29.45 Million HKD | 0.0% |
| 2014 Q3 | 83.07 Million HKD | 0.0% |
| 2014 FY | 33.02 Million HKD | -65.13% |
| 2014 Q1 | 94.69 Million HKD | 0.53% |
| 2013 Q4 | 94.19 Million HKD | -78.1% |
| 2013 FY | 94.69 Million HKD | -45.71% |
| 2013 Q1 | 174.43 Million HKD | 0.0% |
| 2013 Q2 | 430.03 Million HKD | 146.54% |
| 2013 Q3 | 430.03 Million HKD | 0.0% |
| 2012 Q1 | 129.39 Million HKD | 0.0% |
| 2012 FY | 174.43 Million HKD | 34.81% |
| 2012 Q2 | 138.4 Million HKD | 6.96% |
| 2012 Q3 | 138.4 Million HKD | 0.0% |
| 2012 Q4 | 174.43 Million HKD | 26.03% |
| 2011 Q1 | 74.03 Million HKD | 0.0% |
| 2011 Q4 | 129.39 Million HKD | 1.16% |
| 2011 FY | 129.39 Million HKD | 74.78% |
| 2011 Q3 | 127.91 Million HKD | 0.0% |
| 2010 Q1 | 86.21 Million HKD | 0.0% |
| 2010 Q3 | 101.34 Million HKD | 0.0% |
| 2010 FY | 74.03 Million HKD | -14.13% |
| 2009 FY | 86.21 Million HKD | -45.62% |
| 2008 FY | 158.54 Million HKD | -24.07% |
| 2007 FY | 208.79 Million HKD | -8.83% |
| 2006 FY | 229.01 Million HKD | 117.69% |
| 2005 FY | 105.2 Million HKD | -1.29% |
| 2004 FY | 106.58 Million HKD | -21.38% |
| 2003 FY | 135.57 Million HKD | 16.26% |
| 2002 FY | 116.62 Million HKD | 91.6% |
| 2001 FY | 60.86 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 7.05 Billion HKD | 97.835% |